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ttp://dx.doi.org/10.1016/j.ajpath.2014.03.014Disrupted cholesterol homeostasis has been reported in Alzheimer disease and is thought to contribute
to disease progression by promoting amyloid b (Ab) accumulation. In particular, mitochondrial
cholesterol enrichment has been shown to sensitize to Ab-induced neurotoxicity. However, the mo-
lecular mechanisms responsible for the increased cholesterol levels and its trafﬁcking to mitochondria
in Alzheimer disease remain poorly understood. Here, we show that endoplasmic reticulum (ER) stress
triggered by Ab promotes cholesterol synthesis and mitochondrial cholesterol inﬂux, resulting in
mitochondrial glutathione (mGSH) depletion in older age amyloid precursor protein/presenilin-1 (APP/
PS1) mice. Mitochondrial cholesterol accumulation was associated with increased expression of
mitochondrial-associated ER membrane proteins, which favor cholesterol translocation from ER to
mitochondria along with speciﬁc cholesterol carriers, particularly the steroidogenic acute regulatory
protein. In vivo treatment with the ER stress inhibitor 4-phenylbutyric acid prevented mitochondrial
cholesterol loading and mGSH depletion, thereby protecting APP/PS1 mice against Ab-induced
neurotoxicity. Similar protection was observed with GSH ethyl ester administration, which replenishes
mGSH without affecting the unfolded protein response, thus positioning mGSH depletion downstream
of ER stress. Overall, these results indicate that Ab-mediated ER stress and increased mitochondrial
cholesterol trafﬁcking contribute to the pathologic progression observed in old APP/PS1 mice, and that
ER stress inhibitors may be explored as therapeutic agents for Alzheimer disease. (Am J Pathol 2014,
184: 2066e2081; http://dx.doi.org/10.1016/j.ajpath.2014.03.014)Supported in part by Plan Nacional de Investigación Cientíﬁca, Desar-
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Disclosures: None declared.Since the initial observation that feeding rabbits with a
cholesterol-enriched diet leads to amyloid b (Ab) accumu-
lation,1 the number of studies linking cholesterol and Ab
metabolism have increased exponentially. Although the
impact of cholesterol in clinical studies remains unsettled,
cumulating evidence indicates increased cholesterol levels
in brain from Alzheimer disease (AD) patients.2e5 More-
over, ﬁndings in animal and cultured-cell models demon-
strate that cholesterol enrichment in lipid rafts fosters Ab
production6e8 and aggregation,9 and inhibits the intracellular
degradation of the peptide.10 By using mouse models of
cholesterol loading, namely sterol regulatory element binding
protein 2 (SREBP-2) transgenic mice and Niemann-Pick
type C1 knockout mice, we have shown that the trafﬁcking
of cholesterol to mitochondria depletes mitochondrial
glutathione (mGSH), which in turn exacerbates Ab-inducedstigative Pathology.
.oxidative neuronal death.11 Furthermore, in the amyloid
precursor protein/presenilin-1 (APP/PS1) transgenic mouse
the overexpression of the endoplasmic reticulum (ER)-resi-
dent transcription factor SREBP-2 accelerated and worsened
Ab, ER Stress, and Cholesterolkey pathologic manifestations of AD, correlating with
mitochondrial cholesterol loading and mGSH depletion.12
Consequently, in vivo mGSH recovery in APP/PS1 mice
signiﬁcantly reduced Tau pathology and Ab depositions.12
Interestingly, increased mitochondrial cholesterol levels,
concomitant with reduced mGSH content, also were ob-
served in old APP/PS1 mice after Ab accumulation,11 sug-
gesting that Ab per se can regulate cellular cholesterol.
However, although the role of APP and the amyloidogenic
processing on cholesterol homeostasis disruption has been
suggested previously,2,13e15 the molecular mechanisms
remain largely unknown.
Previous studies have reported that moderate ER stress can
deregulate lipid metabolism.16 The cellular response to alle-
viate the ER stress is elicited by the stress transducers inositol-
requiring protein 1 (IRE1), activating transcription factor 6
(ATF6), and protein kinase R (PRKR)-like endoplasmic re-
ticulum kinase (PERK) that trigger a signaling pathway called
the unfolded protein response (UPR). In particular, the
engagement of the PERK pathway has been involved in the
activation of SREBPs.17e19Conversely, overexpression of the
chaperone glucose regulated protein 78 (GRP78) has been
described to inhibit the expression of SREBP-1c and SREBP-
2 proteins.20 ER stress is an early event in AD and has been
implicated indirectly as a mediator of Ab neurotoxicity,21e25
whereas caspase-12 and caspase-4 have been reported as in-
termediates of the ER stress-speciﬁc apoptosis triggered
by Ab.26,27 Hence, these studies lead us to hypothesize that
Ab-induced ER stress might be an additional mechanism
contributing to the increased brain cholesterol content
observed in AD, as a result of enhanced SREBP-2 processing.
By using 2- to 15-month-oldAPP/PS1mice and the SH-SY5Y
cell line we examined the regulatory role of ER stress on
cholesterol and mGSH levels and further analyzed the impact
of these alterations on neuronal death. In vivo treatment of
APP/PS1 mice with ER stress inhibitors restored the mito-
chondrial cholesterol homeostasis, replenished mGSH, and
blocked Ab-mediated cell death and neurotoxicity. A similar
degree of protection was observed in APP/PS1 mice treated
with GSH ethyl ester, which prevented mGSH depletion
without affecting ER stress. These data provide evidence that
ER stress contributes to Ab-induced neurotoxicity, at least in
part by increasing mitochondrial cholesterol accumulation,
which leads to impaired mitochondrial antioxidant defense.
Materials and Methods
APP/PS1 and SREBP-2 Mice
Breeding pairs of B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J
(APP/PS1) and B6;SJLTg(rPEPCKSREBF2)788Reh/J
(SREBP-2) mice were purchased from The Jackson Labo-
ratory (Bar Harbor, ME) and characterized as previously
described.11 Brieﬂy, at the time of weaning (21 days), mice
were identiﬁed genetically by PCR using DNA from ear-tips
and following the genotyping protocols provided by theThe American Journal of Pathology - ajp.amjpathol.orgsupplier. We observed an age-dependent increase of brain
cholesterol levels in female wild-type (WT) mice compared
with male mice (not shown). Therefore, although female
APP/PS1 mice have a more pronounced AD phenotype, in
the present study we focused on male transgenic and WT
mice to minimize variability caused by sex differences. All
procedures involving animals and their care were approved
by the ethics committee of the University of Barcelona and
were conducted in accordance with institutional guidelines in
compliance with national and international laws and policies.
Subcellular Fractionation to Isolate Mitochondria, ER,
and MAM Puriﬁcation
Brains were removed of olfactory bulbs, midbrain, and
cerebellum, and were homogenated in 210 mmol/L
mannitol, 60 mmol/L sucrose, 10 mmol/L KCl, 10 mmol/L
sodium succinate, 1 mmol/L ADP, 0.25 mmol/L dithio-
threitol, 0.1 mmol/L EGTA, and 10 mmol/L HEPES, pH
7.4. Homogenates were centrifuged at 700  g for 10 mi-
nutes, and the supernatants were centrifuged at 10,000  g
for 15 minutes. The resulting pellet (crude mitochondria)
was suspended in 2 mL, loaded onto 8 mL of 30% (v/v)
Percoll (GE Healthcare Bio-Sciences AB, Uppsala, Sweden)
gradient, and centrifuged at 95,000  g for 30 minutes. The
mitochondrial pellet then was rinsed twice by centrifuging
for 15 minutes at 10,000  g. To isolate mitochondria from
cell culture, 5  107 SH-SY5Y cells were trypsinized and
rinsed ﬁrst in PBS and then in hypotonic buffer (20 mmol/L
HEPES, 5 mmol/L KCl, and 1.5 mmol/L MgCl2, pH 8.0).
After centrifugation at 800  g for 2 minutes the resulting
pellet was resuspended in three volumes of hypotonic buffer
and incubated for 10 minutes on ice. Then, cells were dis-
rupted by four aspirations through a 30-gauge needle.
Mannitol-sucrose-HEPES buffer (2.5) (50 mmol/L
HEPES, 525 mmol/L mannitol, 175 mmol/L sucrose, and 5
mmol/L EDTA, pH 8.0) was added to the lysates before
centrifuging at 1500  g for 5 minutes. The postnuclear
supernatant was separated further through a 14% Percoll
density gradient and centrifuged at 12,000  g for 20 mi-
nutes. Loose mitochondrial pellets were rinsed in 210 mmol/
L mannitol, 60 mmol/L sucrose, 10 mmol/L KCl, 10 mmol/
L sodium succinate, 0.1 mmol/L EGTA, and 10 mmol/L
HEPES, pH 7.4, by centrifuging for 10 minutes at 8000  g.
In both cases (brain and SH-SY5Y cells), mitochondrial
purity was examined for cross-contamination with ER and
plasma membrane by Western blot analysis.
ER and mitochondria-associated ER membrane (MAM)
were isolated according to the Wieckowski et al28 protocol.
Postnuclear supernatant (S1) was centrifuged at 9000  g
for 10 minutes to further process supernatants (S2) and
pellets (P2). The ER fraction was obtained by washing the
S2 supernatant at 20,000  g for 15 minutes, followed by
centrifugation at 100,000  g for 1 hour to collect the pellet.
In parallel, P2 was centrifuged twice at 10,000  g before
centrifugation on a 30% Percoll gradient to obtain the lower2067
Barbero-Camps et alband, which contains mitochondria, and the upper band,
which contains MAM, which were collected and washed
further to remove any Percoll contaminants.
Cell Culture and Treatments
The SH-SY5Y human neuroblastoma cell line was obtained
from the European Collection of Cell Cultures (Sigma-
Aldrich, St. Louis, MO) and grown in Dulbecco’s modiﬁed
Eagle’s medium/Ham’s nutrient mixture F12 (Invitrogen,
Life Technologies, Carlsbad, CA), containing 10% fetal
bovine serum and 2 mmol/L glutamine. Cells were plated at
a density of 0.5  106 cells/well. Twenty-four hours after
plating, cells were treated with 10 mmol/L oligomeric Ab
(Bachem AG, Bubendorf, Switzerland), 2 nmol/L thapsi-
gargin (Sigma-Aldrich), 5 mmol/L 4-phenylbutyric acid
(PBA) (Enzo Life Sciences, Farmingdale, NY), 50 mmol/L
salubrinal (Calbiochem, Merck Millipore, Billerica, MA),
100 mmol/L tauroursodeoxycholic acid (Calbiochem, Merck
Millipore), or 1 nmol/L gonadotropin-releasing hormone
(Sigma-Aldrich). In some cases, cells were fractionated into
cytosol or mitochondria on digitonin permeabilization of the
plasma membrane as described previously.29
Preparation of Ab Peptides
Human Ab1-42 was dissolved to 1 mmol/L in hexaﬂuoro-
isopropanol and aliquoted into microcentrifuge tubes, then
the hexaﬂuoroisopropanol was evaporated and the peptides
were stored at 20C until use. For oligomeric assembly,
concentrated peptides were resuspended in 5 mmol/L
dimethyl sulfoxide and then diluted to 100 mmol/L in phenol
redefree media and incubated at 4C for 24 hours. Oligo-
meric forms of Ab were conﬁrmed by Western blot as
previously described.11
GSH and Cholesterol Measurements
GSH levels in homogenates and mitochondria were analyzed
by the recyclingmethod.30 For cholesterol determination from
brain, samples were extracted with alcoholic KOH, distilled
water, and hexane (1:1:2, v/v/v). Appropriate aliquots of
the hexane layer were evaporated and used for cholesterol
measurement.31 High-performance liquid chromatography
analysis was performed using a mBondapak C18 10 mm
reverse-phase column (30 cm 4 mm inner diameter; Waters
Corp., Milford, MA), with a mobile phase of 2-propanol/
acetonitrile/distilled water (6:3:1, v/v/v) at a ﬂow rate of 1mL/
min. The amount of cholesterol was calculated from standard
curves and the identity of the peaks was conﬁrmed by spiking
the sample with known standards. Cholesterol levels in
membrane fractions fromERandMAMwere quantiﬁedby the
Ampex Red cholesterol assay (Invitrogen). Samples were
resuspended in the homogenization buffer containing 5%
Triton X-100 (Sigma-Aldrich) and brieﬂy sonicated. Mito-
chondrial cholesterol levels in cells were determined after Ab2068exposure in the presence of the 0.75 mmol/L P450 side-chain
cleavage enzyme (CYP11A1) inhibitor aminoglutethimide.
Western Blot Analysis
Samples (30 to 80 mg of protein per lane) were resolved by
SDS-PAGE and transferred to nitrocellulose membranes.
Blots were probed with the antibodies listed in Table 1.
After overnight incubation at 4C, bound antibodies were
visualized using horseradish-peroxidaseecoupled secondary
antibodies and an ECL developing kit (GE Healthcare Bio-
Science AB). Densitometry of the bands was measured with
QuantityOne software (Bio-Rad Laboratories, Hercules, CA)
and values were normalized to b-actin or glyceraldehyde-3-
phosphate dehydrogenase.
Immunohistochemistry
Parafﬁn-embedded blocks were prepared by sequential
dehydration in graded ethanol and inﬁltration in parafﬁn
before embedding. Blocks were sectioned serially at a
thickness of 5 mm from 1.2 mm through 2.4 mm from
Bregma. Sections were processed according to the avidine
biotineperoxidase staining method (Vectastain ABC kit;
Vector Laboratories, Burlingame, CA). After antigen
retrieval, the endogenous peroxidase was blocked by expo-
sure to 3% H2O2 in methanol for 30 minutes. Samples then
were treated with the avidin/biotin blocking kit (Vector
Laboratories) according to the manufacturer’s instructions
and incubated overnight at 4C with mouse monoclonal anti-
ATF6 (1:500; Acris, San Diego, CA) and mouse monoclonal
antieAb1-42 (1:300; Sigma-Aldrich). After washing with
PBS, sections were incubated for 1 hour with a biotinylated
secondary antibody (1:400), followed by ABC staining for
1 hour. The immunoreaction was visualized with dia-
minobenzidine using a diaminobenzidine-enhanced liquid
substrate system (Sigma-Aldrich). Sections were counter-
stained with hematoxylin (Dako, Glostrup, Denmark).
TUNEL labeling was performed using the in situ Cell Death
Detection Kit (Roche Applied Science, Penzberg, Germany).
Immunoﬂuorescence and Laser Confocal Imaging
Dewaxed hippocampal sections were ﬁrst boiled in citrate
buffer (10 mmol/L sodium citrate, pH 6.0) and incubated
with 0.1 mol/L glycine/PBS for 20 minutes to reduce auto-
ﬂuorescence. The sections were incubated overnight at 4C
with rabbit polyclonal anti-steroidogenic acute regulatory
protein (StAR; 1:500; Abcam, Cambridge, UK), mouse
monoclonal antiemicrotubule-associated protein 2 (MAP2;
1:500; Sigma-Aldrich), and rat monoclonal anti-glial ﬁbril-
lary acidic protein (GFAP, 1:500; Calbiochem Merck Milli-
pore). After washing in PBS, antibody stainingwas visualized
using Alexa Fluor 488 and 594 secondary antibodies (1:400;
Invitrogen, Life Technologies). Confocal images were
collected using a Leica TCS SPE laser scanning confocalajp.amjpathol.org - The American Journal of Pathology
Table 1 Details of the Primary Antibodies Used in This Study
Antibody Source and type Company Dilution
ABCA1 Rabbit polyclonal Novus Biologicals (Littleton, CO) 1:1000
Calregulin (H-170) Rabbit polyclonal Santa Cruz Biotech 1:500
Caspase-3 Rabbit polyclonal Cell Signaling (Danvers, MA) 1:1000
Caspase-12 Rat monoclonal Sigma-Aldrich 1:500
CHOP Mouse monoclonal Cell Signaling 1:1000
COX IV Rabbit polyclonal Cell Signaling 1:1000
Cytochrome c (clone 7H8.2C12) Mouse monoclonal Santa Cruz Biotech 1:500
Phospho-eIF2a Rabbit polyclonal Invitrogen 1:1000
eIF2a Mouse monoclonal Abcam 1:1000
GAPDH (6C5) Mouse monoclonal Santa Cruz Biotech 1:5000
GRP78 Rabbit polyclonal Stressgen (Enzo Life Science) 1:1000
HXK I (G-1) Mouse monoclonal Santa Cruz Biotech 1:200
HMG-CoA reductase Goat polyclonal Santa Cruz Biotech 1:500
INSIG-1 Rabbit polyclonal Abcam 1:1000
MAP2 Mouse monoclonal Sigma-Aldrich 1:500
MFN2 Mouse monoclonal Abcam 1:1000
StARD3 Rabbit polyclonal Abcam 1:1000
Naþ,KþATPase a1 Mouse monoclonal Santa Cruz Biotech 1:500
PACS-2 Goat polyclonal Santa Cruz Biotech 1:200
Phospho-PERK (Thr980) Rabbit polyclonal Cell Signaling 1:1000
PERK Rabbit polyclonal Sigma-Aldrich 1:1000
Rab5A Rabbit polyclonal Santa Cruz Biotech 1:250
Rab7 Goat polyclonal Santa Cruz Biotech 1:250
Sigma receptor (B-5) Mouse monoclonal Santa Cruz Biotech 1:200
SREBP-2 Rabbit polyclonal Abcam 1:1000
StAR Mouse monoclonal Abcam 1:1000
VDAC Rabbit polyclonal Calbiochem (EMD Millipore) 1:500
b-actin Mouse monoclonal Sigma-Aldrich 1:10,000
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MFN2, mitofusin-2; PACS-2, phosphofurin acidic cluster sorting protein 2; VDAC, voltage-dependent
anion-selective channel protein.
Ab, ER Stress, and Cholesterolmicroscope equippedwithUVexcitation, an argon laser, a 63/
1.32 OIL PH3 CS objective, and a confocal pinhole set at 1
Airy unit (Leica Microsystems GmbH, Wetzlar, Germany).
All of the confocal images shown were single optical sec-
tions. Immunoﬂuorescence intensities and colocalization
coefﬁcients were determined using MBF ImageJ software
version 1.43m (NIH, Bethesda, MD).
Real-Time RT-PCR
Real-time RT-PCR ampliﬁcation was performed using the
iScript one-step RT-PCR kit (Bio-Rad Laboratories) withTable 2 Details of the Primers Used in This Study
Name Host Forward sequence
GRP78 H 50-AATGACCAGAATCGCCTGAC-
CHOP H 50-GCGCATGAAGGAGAAAGAAC-
SREBP2 H 50-TGCCATTGGCCGTTTGTGTC-
STAR H 50-ATCTTTTCCGATCTTCTGC-3
Stard4 M 50-GAGAGATGGCTGACCCTGAGA
Stard5 M 50-GACGCGTCGGGCTGG-30
Xbp1 M 50-GGATCTCTAAAACTAGAGGCT
H, human; M, Mus musculus.
The American Journal of Pathology - ajp.amjpathol.orgSYBR Green (Molecular Probes, Life Technologies). The
primer sequences used are listed in Table 2. PCRs were run in
duplicate for each sample. The relative gene expression was
quantiﬁed by the DDCt method.
Analysis of Xbp1 mRNA Splicing
RNA was reverse-transcribed using Xbp1-speciﬁc primers,
described in Table 2, that ampliﬁed a 600-bp cDNA product
encompassing the IRE1 cleavage sites.32 This fragment
was digested further by PstI (New England BioLabs,
Ipswich, MA) to show a restriction site that is lost afterReverse sequence
30 50-CGCTCCTTGAGCTTTTTGTC-30
30 50-ACCATTCGGTCAATCAGAGC-30
3 50-CCCTTCAGTGCAACGGTCATTCAC-30
0 50-CTTGGGCATCCTTAGCAAC-30
-30 50-TCAGACAGTCCTTCCAGTTTGATC-30
50-AACTCCTCAGATGGCCTCCA-30
TGGTG-3 50-AAACAGAGTAGCAGCGCAGACTGC-30
2069
Barbero-Camps et alIRE1-mediated cleavage and mRNA splicing. The PCR
products were resolved on a 2% agarose gel.
Pregnenolone Determination
To assess pregnenolone production, cells were plated in
Dulbecco’s modiﬁed Eagle’s medium phenol-free media
containing 5% fetal bovine serum and 2 mmol/L glutamine.
Cells were exposed to 10 mmol/L Ab with or without pre-
treatment (1 hour) with ER stress inhibitors. After 48 hours of
incubation, new media containing 10 mmol/L of trilostane
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was added
to prevent further processing of pregnenolone, and cells were
left to accumulate it for 48 hours. Media then was recovered
and levels of the steroid hormone precursor were determined
using a human pregnenolone enzyme-linked immunosorbent
assay kit (Diagnostics Biochem Canada, Inc., Dorchester,
ON, Canada), according to the manufacturer’s instructions.
Data were normalized to total protein values.
Statistics
Results are expressed as means  SD of the number of
experiments. Statistical signiﬁcance was examined using the
unpaired, two-tailed Student’s t-test or one-way analysis of
variance with the Dunnett or Bonferroni post hoc multiple
comparisons test when required. P < 0.05 value was
considered statistically signiﬁcant.
Results
Enhanced SREBP-2 Processing and Decreased
ATP-Binding Cassette, Sub-Family A, Member 1
Transporter Expression Correlate with Increased Brain
Mitochondrial Cholesterol Levels in APP/PS1 Mice
We ﬁrst monitored the age-dependent changes in brain
cholesterol levels of APP/PS1 mice. Cholesterol content
in homogenate or isolated mitochondria from brains of APP/
PS1 mice signiﬁcantly increased at 10 months of age
(Supplemental Figure S1A), consistent with previous obser-
vations.11 The increment in the sterol levels was observed in
hippocampus samples from 7-month-old APP/PS1 mice
(Figure 1A), whereas cholesterol levels in cerebellum, a brain
area relatively unaffected in AD, remained unchanged at
10 months of age (Figure 1A). These ﬁndings were accom-
panied by a signiﬁcant depletion of GSH in brainmitochondria
of 10-month-old APP/PS1 mice (Supplemental Figure S1B).
Western blot analysis in the ﬁnal mitochondrial fraction from
10-month-old WT and APP/PS1 mice showed an absence of
plasma membrane and endosome markers, as well as a
negligible presence of PERK and calreticulin compared with
ER fraction. Thus, the contribution from cross-contamination
of other organellar fractions to the higher level of mitochon-
drial cholesterol seen in aged APP/PS1 mice was minimized
(Supplemental Figure S2).2070To relate these observations with pathways leading to
cholesterol synthesis, we analyzed the processing of mature
SREBP-2. The increase in the levels of the transcriptionally
active fragment of SREBP-2 (68 kDa) was ﬁrst detectable at
4 months of age (Figure 1, B and C) and correlated with an
enhanced expression of its target gene encoding the enzyme
3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase, the rate-limiting enzyme of the cholesterol syn-
thesis pathway (Figure 1C). The expression of SREBP-2 and
HMG-CoA reductase further increased in older APP/PS1
mice (Figure 1C), whereas the levels of both peptides
remained unchanged in WT mice at all ages analyzed
(Supplemental Figure S3A). Because SREBP activation is
tightly regulated by levels of insulin-induced gene-1 (INSIG-
1)17,33 we next analyzed its expression in APP/PS1 mice. As
shown, transgenic mice compared with WT mice displayed
decreased levels of INSIG-1 at all ages analyzed (Figure 1D).
Moreover, because of the time lag between the early SREBP-
2 processing (age, 4 mo) and the late increase in cholesterol
levels (age, 10 mo) observed in APP/PS1 mice, we consid-
ered the contribution of alternative mechanisms in regulating
cholesterol homeostasis. For instance, decreased levels of the
ATP-binding cassette transporter, sub-family A, member 1
(ABCA1) have been described in brains of 11-month-old
APP/PS1 mice, with accumulation of cholesterol in cultured
astrocytes resulting from Ab-induced down-regulation of
ABCA1 expression.34 In turn, data from mouse models and
in vitro experiments have suggested that ABCA1 may affect
Ab deposition and clearance by regulating apolipoprotein E
lipidation and brain cholesterol homeostasis.35 Furthermore,
despite the fact that the expression levels of this protein in AD
still are under debate, with studies showing high levels of
ABCA1 in hippocampal tissues from AD patients,36,37
several reports have linked ABCA1 polymorphisms to an
increased risk for AD.35 Interestingly, when the levels of the
protein were analyzed in APP/PS1 mice (Figure 1D), we
observed an increase in the expression at 4 and 7 months of
age that decreased to WT levels in 10-month-old mice. The
existence of an impaired cholesterol efﬂux resulting from low
ABCA1 levels associated with an enhanced synthesis may
explain in part the cholesterol increase in old APP/PS1 mice.
Increased Expression of Mitochondrial Cholesterol
Carriers in APP/PS1 Mice
Mitochondria are cholesterol-poor organelles. However,
cholesterol transport to the inner mitochondrial membrane
(IMM) plays a physiological role and is a highly regulated
process.38 Cholesterol trafﬁcking to IMMs is controlled chieﬂy
by StAR, which moves cholesterol from the outer mitochon-
drial membrane to the IMM for metabolism. StAR belongs to a
family of proteins that contain StAR-related lipid transfer do-
mains (StAR-related lipid transfer proteins), of which StARD3
(MLN64) and StARD4 also have been described to allow de-
livery of cholesterol to mitochondria. InWTmice the levels of
StAR and StARD3 were maintained steadily during agingajp.amjpathol.org - The American Journal of Pathology
Ab, ER Stress, and Cholesterol(Supplemental Figure S3B). By contrast, APP/PS1 mice dis-
played high levels of StARD3 at all ages analyzed compared
with WT mice (Figure 2A), whereas StAR increased in 10-
month-old transgenic mice (Figure 2A), concomitant to the
increase of mitochondrial cholesterol observed at this age
(Supplemental Figure S1A). The mRNA expression of
StARD4 also was increased in 10-month-old APP/PS1 mice,
whereas StARD5, which is involved in the transport of
cholesterol between Golgi, ER, and plasma membrane,
remained unchanged (Figure 2B). Immunohistochemical
analysis by confocal microscopy conﬁrmed the increase of
StAR in the hippocampus of 10-month-old APP/PS1 mice
(Figure 2C). The double-labeling showed colocalization be-
tween StAR and the neuronal marker anti-MAP2, but not with
the astrocyte marker glial ﬁbrillary acidic protein (Figure 2, C
and D). Similarly, signiﬁcant up-regulation of StAR and
StARD3 protein levels was observed in SREBP-2 transgenic
mice (Figure 2E), establishing a link between induced
cholesterol synthesis andmitochondrial cholesterol trafﬁcking.
Furthermore, differences in the time expression of both
cholesterol carriers betweenAPP/PS1 and TgeSREBP-2mice
highly suggest that although StARD3 may be regulated by the
transcription factor SREBP-2, the induction of StAR expres-
sion requires high levels of cholesterol, but is not directly
dependent on SREBP-2 activation.
In addition to StAR-related lipid transfer proteins as medi-
ators of mitochondrial cholesterol transport, recent studies
have suggested the involvement of MAMs. MAMs areThe American Journal of Pathology - ajp.amjpathol.orgmolecular hubs that regulate several aspects of mitochondrial
biology, ranging from calcium transmission to lipid meta-
bolism,39 including cholesterol homeostasis.40,41 Moreover,
data from experimental AD models have shown increased
MAM function as determined by cholesteryl ester and phos-
pholipid synthesis,42 accompanied by high levels of MAM-
associated proteins, including the sigma-1 receptor,43 and
suggest that these interaction sites may contribute to AD pa-
thology. To evaluate the role of MAMs on the enhanced
mitochondrial cholesterol transport observed in old APP/PS1
mice, we ﬁrst testedwhether cholesterol enrichment in isolated
MAMs was similar to that of mitochondria. As previously
reported, cholesterol levels were higher in MAM fractions
compared with the total content in the ER (Figure 2F). How-
ever, we did not ﬁnd signiﬁcant differences between WT and
APP/PS1 mice in either ER or in the MAM subdomains
(Figure 2F). As indicators of increased area of apposition be-
tween ER and mitochondria we next evaluated the levels of
phosphofurin acidic cluster sorting protein 2 and mitofusin-2,
both are proteins that are required to regulate the contact sites
between the two organelles.44,45 As shown, Western blot
analysis showed similar levels of both peptides in MAMs
isolated from brain extract of WT and APP/PS1 mice
(Figure 2G). Conversely, the levels of the sigma-1 receptor and
voltage-dependent anion-selective channel protein were
increased signiﬁcantly in MAMs from APP/PS1 mice
(Figure 2G), suggesting that these MAM-associated proteins,
previously proposed to facilitate cholesterol translocation fromFigure 1 Expression levels of cholesterol
biosynthesis-related proteins. A: Cholesterol
levels. B: Western blot analysis of SREBP-2 protein
levels in brain extracts from WT mice and APP/PS1
(A/P) mice at the indicated ages. C: Western blot
analysis of SREBP-2 and HMG-CoA reductase
(HMGCR) proteins in brain extracts from 10-
month-old WT mice and APP/PS1 mice at
different ages. D: Representative immunoblots of
INSIG-1 and ABCA1 presence in brain extracts
from WT mice and APP/PS1 mice at the indicated
ages. Relative intensity values are densitometric
values of the bands representing the speciﬁc
protein immunoreactivity normalized with the
values of the corresponding b-actin bands.
*P < 0.05, **P < 0.01 versus WT mice values by
unpaired, two-tailed Student’s t-test (A, B, and D)
and one-way analysis of variance with the Dunnett
post hoc test (C) (n Z 4 to 6). mth, month.
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Figure 2 Expression levels of cholesterol-transporting polypeptides. A: Representative immunoblots of StARD3 and StAR showing an increased presence of
these cholesterol carriers in brain samples from APP/PS1 mice compared with 10-month-old WT mice. B: mRNA levels of StARD4 and StARD5 in brain samples
from WT and APP/PS1 mice at 10 months of age analyzed by quantitative RT-PCR. Absolute mRNA values were determined, normalized to 18S rRNA, and
reported as relative levels compared to the expression in WT mice. C: Representative confocal images of StAR (red) and MAP2 (green) immunoﬂuorescence
labeling of hippocampal sections from 10-month-old WT mice and APP/PS1 mice. D: Representative confocal images of hippocampal sections from 10-month-
old APP/PS1 mice immunostained with anti-StAR (red) and anti-MAP2 or antieglial ﬁbrillary acidic protein (GFAP; green). The extent of colocalization was
quantiﬁed using the linear Pearson correlation coefﬁcient (rp); the resulting scatterplot images are shown on the right. A value of 1.0 indicates complete
colocalization of two ﬂuorescent signals. Note that StAR preferentially colocalizes with neurons labeled with anti-MAP2 compared with astrocytes labeled with
anti-GFAP. E: Western blot analysis of StARD3 and StAR expression in brain from 10-month-old WT mice and TgeSREBP-2 mice at the indicated ages. F: Total
cholesterol in ER and MAMs from brain extracts of 10-month-old WT and APP/PS1 mice. G: Representative immunoblots showing the expression of calreticulin
(calregulin), the sigma-1 receptor (s1R), phosphofurin acidic cluster sorting protein 2 (PACS-2), and the mitochondrial proteins cyclooxygenase 4 (COX IV),
voltage-dependent anion-selective channel protein (VDAC), and mitofusin 2 (MFN2) in ER, MAMs, and mitochondria from 10-month-old WT and APP/PS1 (A/P)
mice. In all Western blot analyses the densitometric values of the bands representing the speciﬁc protein immunoreactivity were normalized with the values of
the corresponding b-actin bands or Ponceau Staining. *P < 0.05, **P < 0.01 versus WT mice values by one-way analysis of variance with the Dunnett post hoc
test (A and E) and the unpaired, two-tailed Student’s t-test (B, C, and G) (n Z 3 to 6). Scale bars: 15 mm (C and D). mito., mitochondria; mth, month.
Barbero-Camps et alER to mitochondria,41,46 may contribute to mitochondrial
cholesterol content in APP/PS1 mice.
Early ER Stress Precedes Mitochondrial Cholesterol
Accumulation in APP/PS1 Mice
Given the cause-and-effect relationship between increased
cholesterol synthesis and enhanced mitochondrial cholesterol2072trafﬁcking and mGSH regulation, we aimed to analyze
further the mechanism responsible for these changes.
Because previous studies had shown that moderate ER stress
modulates the cellular lipid content,16 we explored whether
the Ab-induced ER stress can affect cholesterol homeostasis.
Although no signs of ER stress were detectable inWTmice at
all of the ages analyzed (Supplemental Figure S4A), the UPR
was activated in APP/PS1 mice, with markers showingajp.amjpathol.org - The American Journal of Pathology
 WT    4-mth   7-mth  10-mth 
GRP78
CHOP
p-PERK
APP/PS1
β-actin 0
2
4
6
GRP78
CHOP
    4-mth       7-mth      10-mth
APP/PS1
WT
ytisnetni
evit al e
R
ATF6
APP/PS1WT
*
*
*
p-eIF2α
p-PERK
p-eIF2α
0
20
40
60
80
WT APP/PS1 TUN
1pbX
decil ps
%,
WT APP/PS1
TUN
S
U
Unspliced (480 bp)
Spliced (454 bp)
PstI
*
 7-mth  10-mth 7-mth 10-mth 
GRP78
Tg-SREBP-2
β-actin
p-eIF2α
0
1
2
3 GRP78ytisnetni
evit al e
R
p-eIF2α
*
**
WT
 7-mth 10-mth 7-mth 10-mth 
Tg-SREBP-2WT
*
*
** *
*
eIF2α
eIF2α
PERK
(78 kDa)
(27 kDa)
(78 kDa)
(170 kDa)
(125 kDa)
(40 kDa)
(40 kDa)
(40 kDa)
(40 kDa)
Figure 3 APP/PS1 mice display early ER stress.
A: Representative immunoblots showing the
expression of the chaperonic protein GRP78 and
the ER stress signaling pathway proteins PERK,
phospho-PERK, eIF2a, phospho-eIF2a, and CHOP
in brain extracts from 10-month-old WT mice and
APP/PS1 mice at the indicated ages. B: Immuno-
histochemical staining of ATF6. Representative
photomicrographs of CA1 hippocampus showing
nuclear localization of ATF6 in 7-month-old APP/
PS1 mice (n Z 3). C: Analysis of Xbp1 mRNA
splicing. Total RNAs from brain of 7-month-old WT
and APP/PS1 mice were subjected to RT-PCR as
described in Materials and Methods. After diges-
tion with PstI, the PCR products were resolved in a
2% agarose gel electrophoresis. The PCR products
of Xbp1 mRNA spliced (S) remained intact (454
bp), whereas the unspliced products (U) were cut
into two fragments of 289 and 191 bp, as indi-
cated by the arrows. mRNA from liver of WT mice
treated i.p. with 1 mg/kg 24 hours tunicamycin
(TUN) was used as a positive control (n Z 3). D:
Western blot analysis of GRP78, eIF2a, and
phospho-eIF2a in brain extracts from WT mice and
SREBP-2 transgenic mice. In all Western blot an-
alyses, densitometric values of the bands repre-
senting the speciﬁc protein immunoreactivity were
normalized with the values of the corresponding
b-actin bands. *P < 0.05 versus WT mice values by
one-way analysis of variance with the Dunnett
post hoc test (A), and the unpaired two-tailed
Student’s t-test (D) (n Z 6). Scale bar Z 50
mmol/L (B). mth, month.
Ab, ER Stress, and Cholesterolage-dependent changes (Figure 3A). GRP78 and phospho-
PERK were the earliest markers up-regulated at 4 months of
age (Figure 3A and Supplemental Figure S4B), whereas
eukaryotic initiation factor (eIF)-2a phosphorylation and
C/EBP homologous protein (CHOP) increase were detected in
older APP/PS1 mice (Figure 3A). Moreover, Ab loading par-
alleled ER stress in APP/PS1mice, with hippocampal amyloid
accumulation in intracellular compartments of 4-month-old
APP/PS1 mice (Supplemental Figure S5). APP/PS1 mice also
showed activation of the ATF6-dependent branch of UPR.
ATF6 is processed by the same metalloproteases that activate
SREBPs47 and although previous reports suggested that ATF6
antagonizes the activity of SREBP-2,48 we found nuclear
ATF6 in hippocampal neurons from 7-month-old APP/PS1
mice (Figure 3B). In contrast, compared with tunicamycin-
treated mice, IRE1 phosphorylation and Xbp1 splicing were
not observed inAPP/PS1mice (data not shown andFigure 3C).
The correlation between ER stress and cholesterol accumula-
tion also was noticed in SREPB-2 transgenic mice, which
showed increased GRP78 levels and eIF2a phosphorylation
compared with WT mice (Figure 3D). Thus, APP/PS1 miceThe American Journal of Pathology - ajp.amjpathol.orgshowed an early UPR response that preceded the increase of
cholesterol levels, the increase in the expression of mitochon-
drial cholesterol transporting polypeptides, particularly StAR,
and mGSH depletion.
Ab Induces ER Stress in SH-SY5Y Cells, Resulting in
Increased Mitochondrial Cholesterol Inﬂux and mGSH
Depletion
Once we established that ER stress precedes the disruption in
cholesterol homeostasis in APP/PS1 mice, we analyzed the
link between ER stress and mitochondrial cholesterol loading
by Ab in vitro. We used soluble oligomeric forms of Ab1-42,
previously conﬁrmed by Western blot.11 As shown, Ab1-42
exposure increased the expression ofGRP78 andCHOP at the
mRNA (Figure 4A) and protein levels (Figure 4B) over time
in SH-SY5Y cells. These ﬁndings were accompanied by
eIF2a phosphorylation (Figure 4B), conﬁrming the involve-
ment of the PERK branch observed in APP/PS1 mice.
This outcome preceded the increased expression of tran-
scription factor SREBP-2 and StAR by Ab both at the2073
Figure 4 ER stress induced by oligomeric Ab1-42 promotes mitochondrial cholesterol transport and mGSH depletion in SH-SY5Y cells. GRP78,
p-eIF2a, and CHOP expression levels in cells treated with 10 mmol/L Ab at the indicated time points, analyzed by quantitative RT-PCR (A) and Western
blot (B). SREBP-2 and StAR expression levels after exposure to 10 mmol/L Ab at the indicated time points, analyzed by quantitative RT-PCR (C) and
Western blot (D). E: mRNA levels of SREBP-2 and StAR after incubation with 2 mmol/L thapsighargin (TG) at the indicated time points, analyzed by
quantitative RT-PCR. mRNA values were normalized to 18S rRNA and reported as relative levels compared to the expression in WT mice. F: Mitochondrial
cholesterol levels after incubation with 10 mmol/L Ab for 48 hours, and 0.75 mmol/L inhibitor aminoglutethimide was added for the last 24 hours. G:
Quantiﬁcation of pregnenolone delivered to media as indicator of mitochondrial cholesterol loading. Cells were exposed to 10 mmol/L Ab with or
without 5 mmol/L PBA, 50 mmol/L salubrinal (SAL), or 100 mmol/L tauroursodeoxycholic acid (TUDCA) pretreatment for 1 hour. After 48 hours of
incubation new media containing 20 mmol/L of trilostane was replaced and cells were left to accumulate the steroid hormone for 48 hours. Preg-
nenolone levels in media were determined as described in Materials and Methods. As a positive control, cells were treated with 1 nmol/L gonadotropin-
releasing hormone (GnRH) for 48 hours. Western blot analysis of the mitochondrial cholesterol carriers StAR and StARD3 in cellular extracts (H) and
mitochondrial GSH levels after 4 days of 10 mmol/L Ab incubation with or without 5 mmol/L PBA, 50 mmol/L SAL, or 100 mmol/L TUDCA pretreatment
for 1 hour (I). In all of the Western blot analyses densitometric values of the bands representing the speciﬁc protein immunoreactivity were normalized
with the values of the corresponding b-actin bands. *P < 0.05 versus control values; yP < 0.05, yyP < 0.01 versus Ab treatment values by one-way
analysis of variance with the Dunnett post hoc test (AeE), the unpaired, two-tailed Student’s t-test (F), and one-way analysis of variance with the
Bonferroni multiple comparisons test (G-I) (n Z 3 to 6).
Barbero-Camps et al
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Figure 5 Treatment with the chemical chaperone PBA restores cholesterol homeostasis and provides protection against ER stresseinduced cell death in
APP/PS1 mice. Fifteen-month-old mice were treated i.p. with 500 mg/kg/d PBA for 2 weeks (nZ 6 mice per group) and levels of ER stress markers, caspase
activation, and cholesterol-related proteins were analyzed by Western blot. A: Representative immunoblots of GRP78 and CHOP presence in brain extracts. B:
Representative immunoblots of caspase-12 and caspase-3 cleavage; arrows show fragmented caspase-12 (Csp12) (w42 kDa) and cleaved caspase-3 active
fragment (Csp3) (17 kDa). C: Representative images of apoptotic cells in hippocampus from 15-month-old WT and APP/PS1 mice with or without PBA or GSHee
(i.p. 1.25 mmol/kg/d for 2 weeks) assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). D: Representative immu-
noblots showing a signiﬁcant reduction of SREBP-2, StARD3, and StAR in brain samples from APP/PS1 mice after PBA treatment. Mitochondrial cholesterol
content (E) and mGSH levels (F). In all Western blot analyses densitometric values of the bands representing the speciﬁc protein immunoreactivity were
normalized with the values of the corresponding b-actin bands. *P < 0.05, **P < 0.01 versus WT values; yP < 0.05, yyP < 0.01 versus APP/PS1 mice without
treatment by one-way analysis of variance with the Bonferroni multiple comparisons test (n Z 3 to 6). Scale bar Z 50 mmol/L (C).
Ab, ER Stress, and CholesterolmRNA and protein levels (Figure 4, C and D). Similar
ﬁndings were observed when SH-SY5Y cells were exposed
to the ER stressor thapsigargin (Figure 4E). Consistent with
the function of StAR in mitochondrial cholesterol traf-
ﬁcking, there was a signiﬁcant increase in cholesterol levels
in isolated mitochondria from SH-SY5Y cells treated withThe American Journal of Pathology - ajp.amjpathol.orgAb for 48 hours (Figure 4F), pointing to the amyloid peptide
as responsible for the mitochondrial cholesterol enrichment
observed in APP/PS1 mice.
To further assess the involvement of the Ab-induced ER
stress we tested the effects of ER stress inhibitors. In ste-
roidogenic cells, cholesterol is metabolized in the IMM by2075
Figure 6 In vivo GSH ethyl ester treatment. WT and APP/PS1 mice were treated i.p. with 1.25 mmol/kg/d GSHee for 2 weeks (nZ 6 mice per group). A:
mGSH levels. B: Representative immunoblots showing the expression levels of SREBP-2 protein and the mitochondrial cholesterol carrier StARD3 in brain
extracts after GSHee treatment. C: Western blots analysis of ER stress markers GRP78 and CHOP levels and the presence of cleaved caspase-12 active fragment
(42 kDa) in brain extracts after GSHee treatment. D: Representative immunoblots of caspase-3 cleavage; arrow shows cleaved active fragment (17 kDa).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels were analyzed as a loading control. In all Western blot analyses densitometric, values of the bands
representing the speciﬁc protein immunoreactivity were normalized with the values of the corresponding GAPDH bands. E: Scheme illustrating the proposed
model by which Ab-induced ER stress would contribute to neuronal death through promoting cholesterol synthesis and translocation to mitochondria. This
cascade of events leading to neuronal death could be counteracted by inhibiting ER stress or by restoring the mGSH levels with GSHee therapy. *P < 0.05,
**P < 0.01 versus WT mice values; yP < 0.05 versus APP/PS1 mice values by one-way analysis of variance with the Bonferroni multiple comparisons test;
n Z (3 to 6). CHOL, cholesterol; Mito., mitochondrial; MMP, mitochondrial membrane permeabilization.
Barbero-Camps et alP450 side-chain cleavage enzyme (CYP11A) and converted
into the steroid precursor pregnenolone. Mitochondrial
cholesterol availability is the rate-limiting step in the steroid
biosynthesis and, therefore, pregnenolone levels can be used2076as a gauge of the rate of mitochondrial cholesterol inﬂux.49
In agreement with the increased mitochondrial cholesterol
levels observed in isolated mitochondria, exposure to
10 mmol/L Ab1-42 resulted in a signiﬁcant increase inajp.amjpathol.org - The American Journal of Pathology
Ab, ER Stress, and Cholesterolpregnenolone levels (Figure 4G). This increase was similar
to that causedbygonadotropin-releasing hormone (Figure 4G),
which has been described previously to modulate steroido-
genesis in SH-SY5Y cells.50 Interestingly, pre-incubation with
different chemical inhibitors of ER stress, including 3 mmol/L
PBA, 50 mmol/L salubrinal, or 100 mmol/L tauroursodeox-
ycholic acid, signiﬁcantly decreased the levels of StARD3 and
StAR protein induced by Ab (Figure 4H) and prevented the
increase of pregnenolone in Ab-exposed cells (Figure 4G). As
expected for mitochondrial cholesterol loading, Ab challenge
depleted mGSH levels (Figure 4I), and this effect was pre-
vented by PBA. Thus, these ﬁndings establish a cause-and-
effect relationship between ER stress triggered by Ab and
mGSH depletion.
ER Stress Contributes to in Vivo Neurotoxicity in
APP/PS1 Mice Due to mGSH Depletion
Although UPR is considered a protective mechanism, it can
initiate an apoptotic cascade if the response persists over
time. To analyze the contribution of ER stress to neuronal
death we tested the role of PBA treatment in vivo (500
mg/kg per day), administered i.p. every 12 hours for 2
weeks, in 15-month-old APP/PS1 mice, when neuro-
degeneration is fully detectable. Treatment with the chap-
erone signiﬁcantly reduced the levels of the ER stress
markers GRP78 and CHOP in APP/PS1 mice (Figure 5A).
Moreover, the proteolytic processing of caspase-12 and
caspase-3 to their active fragments was blocked by PBA
treatment (Figure 5B), resulting in reduced apoptosis in the
hippocampus of APP/PS1 mice (Figure 5C). The use of the
chaperone-like molecule also prevented the expression of
SREBP-2 as well as the increase of the mitochondrial
cholesterol carriers StAR and StARD3 observed in APP/
PS1 mice (Figure 5D). Paralleling these effects, mito-
chondrial cholesterol loading (Figure 5E) and mGSH
depletion (Figure 5F) in APP/PS1 mice were abolished by
PBA therapy, further validating the link between ER stress
and mGSH regulation.
We previously showed that the mGSH content is critical in
regulating the cellular response to different apoptotic stimuli
including tumor necrosis factor-a, hypoxia, or Ab peptides.51
Therefore, it is conceivable to speculate that the protective
effect exerted by PBA may be owing, at least in part, to the
recovery of the pool of mGSH. To further test this hypothesis
mice were administered 1.25 mmol/kg/d GSH ethyl ester
(GSHee) i.p. every 12 hours for 2 weeks. As shown, GSHee
replenished the pool of mGSH (Figure 6A). The expression
of the cholesterol-related proteins SREBP-2 and StARD3, as
well as the increased levels of the ER stress markers GRP78,
CHOP, and cleaved caspase-12, observed in APP/PS1 mice
remained unchanged after GSHee treatment (Figure 6, B and
C). However, GSHee signiﬁcantly reduced the cleavage of
caspase-3 (Figure 6D) and prevented brain apoptosis in APP/
PS1 mice to a similar extent as observed with PBA
(Figure 5C). Overall, these ﬁndings suggest that ER stressThe American Journal of Pathology - ajp.amjpathol.orgcontributes to in vivo Ab neurotoxicity in APP/PS1 mice, at
least in part by depletion of mGSH.
Discussion
A recent lipidomic analysis described a complex landscape of
lipid alterations in speciﬁc brain regions inAD.52Among these,
disruption of cholesterol homeostasis has been described in
AD,2e5 and our recent studies advanced a role for mitochon-
drial cholesterol in Ab-induced neuroinﬂammation and
neurotoxicity.11,12 Here, we analyzed the role of ER stress in
cholesterol homeostasis, mitochondrial cholesterol loading,
and mGSH depletion in APP/PS1 mice (Figure 6E). First, we
observed that APP/PS1 mice show early ER stress and
increased levels of active SREBP-2 associated with decreased
expression of INSIG-1. INSIGs exert their action in the ER by
binding SREBP cleavage-activating protein and preventing it
from escorting SREBPs to the Golgi apparatus where the
SREBPs are processed to their active forms. Interestingly,
INSIG-1 is a short-lived protein, and inhibition of protein
translation processes as a response to ER stress has been shown
to reduce its levels severely,17 thus raising the possibility that a
similar mechanism may take place in APP/PS1 mice, likely
contributing to enhanced processing of SREBP-2.
Despite the presence of active SREBP-2 since 4 months of
age, cholesterol accumulates only in old transgenic mice, and is
ﬁrst detectable in the hippocampus. A potential factor that ac-
counts for this age-dependent difference may be ABCA1
expression, which increases in young transgenic mice but de-
creases in old mice. Although in-depth research would be
needed to discern the exact mechanism, chronic inﬂammatory
conditions41,42 or changes in cerebral oxysterols53,54 might
account for this age-dependent decrease of ABCA1 expression.
A key feature of our ﬁndings is the increased mitochon-
drial cholesterol ﬂux that correlates with depleted mGSH
content. The evidence for this outcome was generated in a
dual fashion. First, the increase in mitochondrial cholesterol
parallels that of pregnenolone in human neuroblastoma
cells challenged with Ab peptide. Because mitochondrial
cholesterol availability is the rate-limiting step in steroido-
genesis,49,55 pregnenolone determination is a surrogate of
mitochondrial cholesterol trafﬁcking to IMM. Second, we
examined the expression of different protein carriers that
potentially involved in cholesterol transport to mitochon-
dria. Unlike StARD3, changes in the expression of StAR
were detectable in 10-month-old APP/PS1 mice, paralleling
the increase of cholesterol in mitochondria, which positions
StAR as most likely responsible for mitochondrial choles-
terol loading. Interestingly, the immunohistologic analyses
show that the increase in StAR is limited to hippocampal
neurons; although we cannot exclude that an enhanced
cholesterol synthesis also may occur in astrocytes, which
are known to be the primary site for cholesterol loading in
adult brain. The relevance of the mitochondrial cholesterol
loading described in APP/PS1 mice is reinforced further by
the reported presence of high StAR levels in affected brains of2077
Barbero-Camps et alAD patients.56 In these studies, the enrichment in StAR was
observed both in hippocampal pyramidal neurons and astro-
cytes. Moreover, although recent studies indicate that StARD3
regulates mitochondrial cholesterol in the absence of Niemann-
Pick type C1,49 it is likely that the differential localization
of StARD3 (endolysosomal) versus StAR (mitochondria)
determines their contribution to mitochondrial cholesterol
regulation. In addition, posttranslationalmodiﬁcations of StAR,
including its phosphorylation at serine residues, have been
described to modulate steroidogenesis.57 The impact of these
factors in promoting mitochondrial cholesterol accumulation in
the APP/PS1 mouse model remains to be established.
Mitochondrial cholesterol trafﬁcking implies two events:
cholesterol transfer to the outer mitochondrial membrane
from extramitochondrial sources and intramitochondrial
cholesterol movement from the outer mitochondrial mem-
brane to IMM for metabolism. StAR plays an essential role
in the latter. Indeed, germline StAR deﬁciency in mice re-
sults in lethal congenital adrenal lipoid hyperplasia,58
meaning that other StAR-related lipid transfer members
cannot replace StAR deﬁciency. A remaining question,
however, is how does cholesterol transfer to the outer
mitochondrial membrane to be available for StAR? We
found increased levels of the sigma-1 receptor and voltage-
dependent anion-selective channel protein, both MAM-
associated proteins, which have been shown to interact
and collaborate with StAR in the transfer of cholesterol from
ER to mitochondria.41,46 The responsiveness of MAM to
ER stress has been described in Ca2þ-dependent mito-
chondrial apoptosis59; in particular, the sigma-1 receptor has
been reported to regulate ER/mitochondrial Ca2þ mobili-
zation under ER stress conditions.60 Moreover, in addition
to these possibilities, caveolin-1 has recently been shown to
regulate mitochondrial cholesterol homeostasis.55 However,
its putative contribution to Ab-mediated mitochondrial
cholesterol loading remains to be investigated. On the other
hand, overexpression of StARD4 in mouse hepatocytes also
has been reported to stimulate bile acid synthesis,61 sup-
porting its role of cholesterol transport to mitochondria.
Furthermore, by using cholesterol-containing liposomes as
donors, a recent study62 showed that recombinant StARD4
accelerates cholesterol transfer to isolated liver mitochon-
dria. Consistent with these studies, we found a 1.5- to 2-fold
increase of Stard4 mRNA levels in 10-month-old APP/PS1
mice whereas Stard5 levels remained unchanged, consistent
with its inability to transfer cholesterol to mitochondria.63,64
Previous data have indicated that StARD5 expression was
up-regulated by ER stress63; however, the transcriptional
induction of StARD5 is mediated by XBP1,65 a signal
transducer that was unprocessed and therefore inactive in
the ER stress response displayed by APP/PS1 mice.
We observed an early activation of the UPR, coinciding
with the burst of Ab generation in 4-month-old APP/PS1
mice, and the induction of cholesterol synthesis, indicating
that Ab-induced ER stress can play a role in this alteration.
In support of this link, we observed that Ab-induced ER2078stress in SH-SY5Y cells stimulates the expression of
SREBP-2 and StAR. The ER stressor thapsigargin repro-
duced these ﬁndings, conﬁrming and extending the initial
observations describing a link between ER stress and
cholesterol synthesis.16,66 Moreover, Ab exposure resulted in
accumulation ofmitochondrial cholesterol and pregnenolone,
indicating that Ab promotes cholesterol ﬂux to mitochondria.
The efﬁcacy of different ER stress inhibitors in normalizing
the expression of StARD3 and StAR and reducing the hor-
mone levels, further proved that this effect was mediated via
ER stress. Consistent with these data, we recently provided
compelling evidence in hepatocytes that StAR is an ER stress
target gene whose expression, induced by tunicamycin, is
prevented by tauroursodeoxycholic acid.67 Finally, we
observed that the Ab-enhanced mitochondrial cholesterol
inﬂux is accompanied by signiﬁcant mGSH depletion. The
link between these events, namely increased cholesterol and
mGSH depletion, is owing to the sensitivity of the mGSH
carrier to changes in membrane dynamics induced by
cholesterol accumulation inmitochondrial membranes.68 The
reduction of mGSH levels was prevented by the chemical
chaperone PBA, suggesting a key role of Ab-induced ER
stress in controlling the mitochondrial antioxidant defense.
APP/PS1 mice display speciﬁc UPR signaling, charac-
terized by selective PERK and ATF6 activation, without
IRE1a phosphorylation and Xbp1 processing. Although the
underlying mechanisms contributing to this particular UPR
branch activation are unknown, initial observations have
described that mutations in PS1 increased the vulnerability
to ER stress owing to a down-regulation of the UPR, caused
by disturbed function of the IRE1a.69 Whether this partic-
ular UPR signaling is a speciﬁc feature of APP/PS1 mice
has yet to be conﬁrmed.
ER stressemediated cell death has been linked consistently
to Ab neurotoxicity.21,23,24 Consistent with these ﬁndings,
APP/PS1 mice showed increased processing of caspase-12
and caspase-3 associated with neuronal death, which was
reduced signiﬁcantly by inhibiting ER stress. Moreover,
in vivo treatment with PBA also normalized the expression of
SREBP-2 and that of StAR and StARD3 in APP/PS1 mice,
preventing mitochondrial cholesterol accumulation. Recent
studies in Tg2576 and APP/PS1 mice show that chronic
administration of PBA is accompanied by clearance of Ab,
reduced Tau pathology, and reversal of learning deﬁcits.70e72
In addition to its established role as an anti-ER stress agent,
PBA has been shown to inhibit histone deacetylases, which
may contribute to PBA-mediated effects by restoring the
transcription of proteins involved in synaptic plasticity and
structural remodeling. Histone deacetylase inhibitors also
have been described to modulate cholesterol homeostasis,
favoring cholesterol trafﬁcking and degradation.73e75 How-
ever, the fact that other ER stress inhibitors such as salubrinal
and tauroursodeoxycholic acid can modulate cholesterol ho-
meostasis minimizes the potential contribution of histone
deacetylase inhibition by PBA, further supporting an ER
stressedependent mechanism.ajp.amjpathol.org - The American Journal of Pathology
Ab, ER Stress, and CholesterolWeobserved a signiﬁcant recovery of themGSH content in
cells and APP/PS1 mice that was associated with PBA-
induced cholesterol normalization. Given the key role of
mGSH in controlling the oxidative stress generated in mito-
chondria,51 we inferred that part of the ER stressemediated
cell death in the transgenic mice resulted from a compromised
mitochondrial antioxidant defense that sensitizes cells to Ab
insult. To conﬁrm this hypothesis, mice were administered
GSHee, which signiﬁcantly recovered the mitochondrial pool
of GSH in APP/PS1 mice. As expected, the treatment did not
modify the levels of ER stress or the increased brain choles-
terol content displayed by the transgenic mice, but signiﬁ-
cantly reduced caspase-3 cleavage and neuronal death, to the
same extent as PBA treatment, highlighting the key role of
mGSH in regulating ER stressemediated neuronal death. It is
worth noting that TgeSREBP-2 mice also showed ER stress
associated with enhanced mitochondrial cholesterol loading
and depletedmGSH levels,11whereas no signs of apoptosis or
Ab accumulationwere observed in thesemice during aging,12
indicating that altered cholesterol homeostasis per se is not
sufﬁcient to initiate the disease.
Taken together, our ﬁndings point to ER stress as a link
between Ab and cholesterol up-regulation and subsequent
mitochondrial trafﬁcking (Figure 6E). Moreover, although
the relative contribution of neuronal and glial cells has to be
established, the histochemical analyses show an increased
presence of StAR and nuclear ATF6 in the hippocampal
pyramidal cell layer of transgenic mice, indicating that
deregulated cholesterol homeostasis and ER stress is present
in neurons. In addition, the data uncover mGSHdepletion as a
key mechanism of ER stress-mediated neurotoxicity in APP/
PS1 mice. This view is of particular relevance given recent
ﬁndings suggesting a feed-forward loop between ER stress
and Ab processing in AD,76 with the expected consequences
of mitochondrial cholesterol loading and mGSH depletion
contributing to Ab-mediated neurotoxicity. Thus, therapeutic
strategies targeting ER stress and resulting in the restoration
of mGSH may be of signiﬁcance in the treatment of AD.
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